Pamela L Kunz

7PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targetsIndustrial and employee relationsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 09, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

Kimberly Perez, Jaydira Del Rivero, Erin B Kennedy

|Dec 14, 2023
Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms.

Divya M Gupta, James Barnes, FeiFei Qin

|Sep 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

Jaydira Del Rivero, Kimberly Perez, Erin B Kennedy

|Nov 04, 2022
Where Are All the Women in Industry Advisory Boards?

Rachna T Shroff, Karyn A Goodman, Janice M Mehnert

|Oct 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Pamela L Kunz, Noah T Graham, Paul J Catalano

|Sep 27, 2022
Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era.

Stephanie L Graff, Tanya Wildes, Narjust Duma

Pageof 2